Even today, tuberculosis remains a public health problem ofenormous importance, and a leading infectious cause ofdeath among adults in many developing countries. The rapid spread of HIV and its close and deadly association with tuberculosis poses a great challenge toAsia. As has al ready been seen in Africa, TB notifications have either doubled or quadrupled, attributed primarily to HIV. Although the overall impact in Asia is not substantially visible, it is essential that the national AIDS and TB programmes work together and build partnerships to minimise the potential impact of HIV/TB in countries of the region.
Get full access to this article
View all access options for this article.
References
1.
Agarwal, A., P.S. Narendra, T.S. Dinamani and N.S. Devendra (1998). Survival of AIDS patients in Manipur, India. International Conference of AIDS, 12, 1015 (abstract no. 60078).
2.
Chaisson, R.E. et al. (1998). A randomised trial of rifampicin/pyrazinamide for two months vs INH for 12 months in HIV+, tuberculin+ adults. Twelfth World AIDS Conference, Geneva (Abstract 22126).
3.
Chequer, P., E.C. Sudo, M.A.A. Vitfria, V.G. Veloso and E.A. Castilho (2000). The impact of antiretroviral therapy in Brazil . Presented at the XIII International AIDS Conference , Durban (abstract M.P.E. 1066).
4.
Fatkenheuer, G., H. Taelman, P. Lepage, A. Schwenk and R. Wenzel (1999). The return of tuberculosis. Diagnostic Microbiology and Infectious Disease, 34(2), 139-46.
5.
Girardi, E. et al. (2000). Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS, 14(13), 1985-91.
6.
Halsey, N.A., J.S. Coberly, J. Desormeaux, P. Losikoff, J. Atkinson, L.H. Moulton, M. Contave, M. Johnson, H. Davis, L. Geiter, E. Johnson, R. Huebner, R. Boulos and R.E. Chaisson (1998). Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet, 351(9105), 786-92.
7.
International Union against Tuberculosis and Lung Disease (IUATLD) (1998). Treatment regimens in HIV infected tuberculosis patients: An official statement of the International Union against Tuberculosis and Lung Disease, Paris, September 1997. International Journal of Tuberculosis and Lung Diseases, 2(2),175-78.
8.
Kumarasamy, N., S. Solomon, S.A. JayakerPatul, R. Venilla and R.E. Amalraj (1995). Spectrum of opportunistic infections among AIDS patients in Tamil Nadu, India. International Journal of STD and AIDS, 6(6), 447-49.
9.
Ministry of Public Health (MOPH), Thailand, WHO and JICA (2000). Assessment: Isoniazib preventive therapy (IPT) for people living with HIV in upper north of Thailand. December, available at http://www.stoptb.org/Working_Groups/ TBHIV/WHO_Thailand/Assessment_IsoniazidPreventive.htm.
10.
Mocroft, A., S. Vella, T.L. Benfield, A. Chiesi, V. Miller, P. Gargalianos, A. d'Arminio Monforte, I. Yust, J.N. Bruun, A.N. Phillips and J.D. Lundgren (1998). Changing patterns of mortality across Europe in patients infected with HIV-1: EuroSIDA Study Group. Lancet , 352 (9142), 1725-30.
11.
Mohanty, K.C. and P.M.M. Basheer (1995). Changing trend of HIV infection and tuberculosis in a Bombay area since 1988. Indian Journal of Tuberculosis , 42(2), 117-20.
12.
Murray,J.F. (1990). Cursed duet: HIV infection and tuberculosis. In H. Herzog (ed.), Respiration (pp. 210-20). Basel: S. Karger AG.
13.
Narain, J.P., M.C. Raviglione and O. Kochi (1992). HIV associated tuberculosis in developing countries: Epidemiology and strategy for prevention. Tubercleand LungDisease , 73(6), 311-21.
14.
Narain, J.P., S.P. Tripathy and E. Pontali (2002). Tuberculosis and HIV infection. In Jai P. Narain (ed.), Tuberculosis: Epidemiology and control (pp. 84-100). New Delhi: WHO Regional Office for South-East Asia.
15.
Nunn, P., M. Mungai, J. Nyamwaya, C. Gicheha, R.J. Brindle, D.T. Dunn, W. Githui, J.O. Were and K.P.W.J. McAdam (1994). The effect of Human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tubercle and Lung Disease, 75(1), 25-32.
16.
Palella, F.J. Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman and S.D. Holmberg (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators. New England Journal of Medicine, 338, 853-60.
17.
Paranjape, R.S., S.P. Tripathy, P.A. Menon, S.M. Mehendale, P. Khatavkar, D.R. Joshi, U. Patil, D.A. Gadkari and J.J. Rodrigues (1997). Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian Journal of Medical Research, 106, 207-11.
18.
Punnotok, J., N. Shaffer, T. Naiwatanakul, O. Pumprueg, P. Subhannachart, A. Iffiravivongs, C. Chuchotthaworn, P. Ponglertnapagorn, N. Chantarojwong, N.L. Young, K. Limpakarnjanarat and T.D. Mastro (2000). Human immunodeficiency virus related tuberculosis and primary drug resistance in Bangkok, ThailandInternational Journal of Tuberculosis and Lung Diseases, 4(6), 537-43.
19.
Rajasekaran, S., A. Uma, S. Kamakshi, D. Jeyaganesh, A. Senthamizhchelvan, S. Savithri and Gopinathan ( 2000). Trend of HIV infection in patients with tuberculosis in rural South India. Indian Journal of Tuberculosis, 47(4), 223-26.
20.
Sacks, L.V., S. Pendle, D. Orlovic, L. Blumberg and C. Constantinou (1999). A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital. Clinical Infectious Disease, 29(1), 96-101.
21.
Sapawitkul, S., T. Yoshima, D. Rienthong, P. Akarasewi, N. Kunyanone, S. Saisorn and H. Yanai (1998). Increasing burden of tuberculoisis and high rate of drug resistance in an HIV epicenter in northern Thailand 1989-97. International Conference ofAIDS, 12, 288 (abstract no. 452/22131).
22.
SEARO (2003). Tuberculosis in South-East Asia region: An update. Report, available at http://w3.whosea.org/tb/publications.htm.
23.
Siriarayapon, P., H. Yanai, J.R. Glynn, S. Yanpaisarn and W. Uthaivoravit (2002). Links: The evolving epidemiology of HIV infection and tuberculosis in northern Thailand. Journal of Acquired Immune Deficiency Syndrome, 31(1), 80-89.
24.
Solomon, S., S. Anuradha and S. Rajasekaran (1995). Trend of HIV infection in patients with pulmonary tuberculosis in South India. Tubercle and Lung Disease, 76(1), 17-19.
25.
Sunderam, G., R.J. MacDonald, T. Maniatis, J. Oleske, R. Kapila and L.B. Reichman (1986). Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). Journal of the American MedicalAssociation, 256(3), 362-66.
26.
Tripathy, S.P., D.R. Joshi, P. Menon, R.S. Paranjape, S.M. Mehendale and P. Khatavkar (1996). Seroprevalence of HIV-1 infection in tuberculosis patients at Pune, India. Paper presented at the Ninth International Conference on AIDS, Vancouver, 7-12 July.
27.
Vittinghoff, E., S. Scheer, P. O'Malley, G. Colfax, S.D. Holmberg and S.P. Buchbinder (1999). Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. Journal of Infectious Diseases, 179(3), 717-20.
28.
Who (1997). Treatment of tuberculosis: Guidelines for national programmes. WHO, WHO/ TB/97.220, available at http://www.who.int/gtb/publications/ttgnp/index.htm .
29.
— (1999). Preventive therapy against tuberculosis in people living with HIV. Weekly Epidemiological Record, 74(46), 385-98.
30.
— (2001). First meeting of global working group on TB/HIV . WHO, Geneva, 9-11 April WHO/CDS/TB/2001.293, available at, http://www.who.int/gtb/publications/tb_hiv/2001-293_index.htm.
31.
— (2002a). Strategic framework to decrease the burden of TB/HIV. WHO, Geneva, WHO/CDS/TB/2002.296, available at http://www.who.int/gtb/publications/tb_hiv/2002-296_index.htm.
32.
— (2002b). Scaling up: Antiretroviral therapy in resource-limited settings—Guidelines for a public health approach. WHO.
33.
— (2003). Global tuberculosis control: Surveillance, planning, financing. Report, available at: http://www.who.int/gtb/publications/globrep02/index.html.
34.
— (forthcoming) Guidelines for implementing collaborative TB and HIV programme activities. Geneva: WHO .
35.
Who Searo (2002). The use of antiretroviral therapy: A simplified approach for resource-constrained countries . WHO SEARO.
36.
Yanai, H., W. Uthaivoravit, V. Panich, P. Sawanpanyalert, B. Chaimanee, P. Akarasewi, K. Limpakarnjanarat, P. Nieburg and T.D. Mastro (1996). Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-94. AIDS, 10(5), 527-31.
